Prestwick Pharmaceuticals Inc Watch

EX-10.8

from S-1/A 90 pages License Agreement

12/34/56

EX-10.22

from S-1 12 pages September 19, 2003 Personal and Confidential Mark Vanausdal Evanston, Il Dear Mark

12/34/56

EX-10.21

from S-1 15 pages February 25, 2004 Robert Whitehead C/O Prestwick Pharmaceuticals, Inc. 1825 K Street, Nw, Suite 1475 Washington, D.C. 20006 Dear Bob: This Letter Sets Forth the Substance of the Agreement (The “Agreement”) Between You and Prestwick Pharmaceuticals, Inc., a Delaware Corporation (The “Company”) Regarding Our Mutual Agreement That You Separate From the Company

12/34/56

EX-10.20

from S-1 3 pages August 4, 2003 Benjamin P. Lewis, PH.D., R.PH., Rac 24137 Newbury Road Gaithersburg, MD 20882 Re: Offer Letter Dear Ben

12/34/56

EX-10.19

from S-1 5 pages Prestwick Pharmaceuticals, Inc. 1825 K Street Nw, Suite 1475 Washington, DC 20006 November 1, 2004 Personal and Confidential William H. Washecka 16617 Harbour Town Drive Silver Spring, MD 20905 Dear Bill

12/34/56

EX-10.18

from S-1 5 pages February 4, 2004 Personal and Confidential Jim Shaffer 8905 Barleymoor Drive Raleigh, Nc 27615 Dear Jim

12/34/56

EX-10.17

from S-1 6 pages November 7, 2003 Personal and Confidential Christopher O’brien, MD 906 El Mac Place San Diego, Ca 92106 Dear Chris

12/34/56

EX-10.16

from S-1 5 pages September 2, 2003 Personal and Confidential David Cory San Francisco, Ca Dear David

12/34/56

EX-10.15

from S-1 5 pages Personal and Confidential Melvin D. Booth 8318 Woodlea Mill Road McLean, Va 22102 Dear Mel: Prestwick Pharmaceuticals, Inc. (The “Company”) Is Pleased to Engage You to Assist With the Management of the Company as Set Forth in This Letter Agreement

12/34/56

EX-10.14

from S-1 19 pages License Agreement 1. Definitions

12/34/56

EX-10.13

from S-1 20 pages License Agreement

12/34/56

EX-10.12

from S-1 70 pages Development and Commercialization License and Clinical Supply Agreement by and Between Neurobiotec Gmbh and Prestwick Pharmaceuticals, Inc. 11 September 2003

12/34/56

EX-10.11

from S-1 15 pages Agreement Among Schering Aktiengesellschaft Müllerstrabe 178 13342 Berlin (Hereinafter Called “Schering”) and Neurobiotec Gmbh Tegeler Straibe 6 13353 Berlin (Hereinafter Called “Neurobiotec”) and Prestwick Pharmaceuticals, Inc. 1825 K Street Washington, D.C. 2006 (Hereinafter Called “Prestwick”) 2 Recitals

12/34/56

EX-10.10

from S-1 57 pages (1) Cambridge Laboratories Limited and (2) Prestwick Pharmaceuticals, Inc., Amended and Restated Agreement 17 Hanover Square London W 1 S 1 Hu Tel: 020 7917 8500 Fax: 020 7917 8555

12/34/56

EX-10.9

from S-1 51 pages (1) Cambridge Laboratories Limited and (2) Prestwick Pharmaceuticals, Inc., Agreement for Canadian Rights to Nitoman 17 Hanover Square London W1s 1hu Tel: 020 7917 8500 Fax: 020 7917 8555

12/34/56

EX-10.7

from S-1 13 pages Executive Employment Agreement

12/34/56

EX-10.6

from S-1 56 pages Asset Purchase and Subscription Agreement

12/34/56

EX-10.5

from S-1 17 pages Indemnification Agreement

12/34/56